Microphysiological systems to Assess Pretreatment Immunogenicity and Efficacy (MAGPIE)
AI Overview
Microphysiological systems (iMPS) offer a breakthrough in vaccine development by modeling human immune responses in vitro, bridging the gap between preclinical studies and clinical trials. By accurately predicting vaccine immunogenicity, efficacy, and potential side effects, iMPS can accelerate medical countermeasure discovery for emerging threats to military personnel.
This summary is AI-generated from the official solicitation.
Key Details
Official Description
The Defense Threat Reduction Agency (DTRA) Research and Development Chemical and Biological Technologies Directorate Medical division in support of the Joint Science and Technology Office (JSTO) is charged with addressing the potential threat to the armed services posed by a wide range of pathogenic and toxic agents. In support of warfighter readiness, vaccines build a defense against known and future threats. However, the development of vaccines is stymied by traditional in vitro or in vivo mod...
Read full description on official sourceMore Department of Defense Opportunities
Get Alerts for Opportunities Like This
RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.
Start Free Trial